Together, these results suggest that there are common features in genetic alterations related to the metabolic subtypes across cancer types and that TP53 mutations were associated with glycolytic subtype, while CTNNB1 mutations were correlated to KB-metabolic subtype. This evidence concerns the gene CTNNB1 and cancer.